The Newshound

Statins could cut dementia risk by 15% and slash heart attack odds, landmark studies find

Statins, which can cost as little as 3p per pill, cut dementia risk by up to 15% in a landmark 15-year Danish study of over 132,000 participants.
Statins, which can cost as little as 3p per pill, cut dementia risk by up to 15% in a landmark 15-year Danish study of over 132,000 participants.

Two major studies presented at the world's largest heart conference in Munich have found that the 3p-a-day cholesterol pill could sharply lower dementia risk for millions of Britons not currently taking them. Researchers followed more than 132,000 Danes across 15 years and established that statins can reduce the likelihood of developing dementia by as much as 15% — with earlier use delivering greater protection.

Around six million of the nearly 10 million Britons aged over 70 who do not take statins could stand to benefit, along with the five million Britons living with type 2 diabetes.

The findings were simultaneously published in the Lancet Regional Health Europe journal and presented at the European Society of Cardiology's annual congress.

Experts warn dementia cases globally are forecast to NEARLY TRIPLE to 153 million by 2050, but believe close to half of all cases are preventable or could at least be delayed.

MoreThe TelegraphStatins could cut dementia risk for millionsThe GuardianStatins can reduce dementia risk by up to 15%, long-term study suggestsIrish ExaminerStudy finds statins can lower risk of dementia by 15% - Irish ExaminerPressReaderStatin hope to cut risk of dementia - PressReaderThe SunMillions could benefit from 3p pill ‘to slash risk of heart attack and dementia’
Read today's full feed at The Newshound →